Eisaku Nakamura
Direktor/Vorstandsmitglied bei KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD.
Profil
Eisaku Nakamura is currently an Independent Outside Director at D.
Western Therapeutics Institute, Inc. and Kubota Pharmaceutical Holdings Co. Ltd.
He is also an Auditor at KOINOBORI Associate, Inc. In the past, he worked as a Director at Acucela, Inc.
Aktive Positionen von Eisaku Nakamura
| Unternehmen | Position | Beginn |
|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Direktor/Vorstandsmitglied | 01.03.2016 |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Direktor/Vorstandsmitglied | 29.03.2018 |
| KOINOBORI Associate, Inc. | Comptroller/Controller/Auditor | 01.01.2017 |
Ehemalige bekannte Positionen von Eisaku Nakamura
| Unternehmen | Position | Ende |
|---|---|---|
| ACUCELA INC | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
| KOINOBORI Associate, Inc. |
